Long-term results and recurrence patterns from SCOPE-1: a phase II|[sol]|III randomised trial of definitive chemoradiotherapy |[plus]||[sol]||[minus]| cetuximab in oesophageal cancer

TCrosby; C NHurt; SFalk; SGollins; JStaffurth; RRay; J ABridgewater; J IGeh; DCunningham; JBlazeby; RRoy; TMaughan; GGriffiths; and SMukherjee

首页> 外文期刊>British Journal of Cancer >Long-term results and recurrence patterns from SCOPE-1: a phase II|[sol]|III randomised trial of definitive chemoradiotherapy |[plus]||[sol]||[minus]| cetuximab in oesophageal cancer

【24h】

Long-term results and recurrence patterns from SCOPE-1: a phase II|[sol]|III randomised trial of definitive chemoradiotherapy |[plus]||[sol]||[minus]| cetuximab in oesophageal cancer

机译：SCOPE-1的长期结果和复发模式：定性放化疗的II | [sol] | III期随机试验| [+] || [sol] || [减] |西妥昔单抗在食管癌中的作用

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:The SCOPE-1 study tested the role of adding cetuximab to conventional definitive chemoradiotherapy (dCRT), and demonstrated greater toxicity and worse survival outcomes. We present the long-term outcomes and patterns of recurrence.

机译：背景：SCOPE-1研究测试了将西妥昔单抗添加到常规确定性放化疗中的作用，并显示出更大的毒性和更差的生存结果。我们介绍了长期的结局和复发模式。

著录项

来源
《British Journal of Cancer》 |2017年第6期|共8页
作者
TCrosby; C NHurt; SFalk; SGollins; JStaffurth; RRay; J ABridgewater; J IGeh; DCunningham; JBlazeby; RRoy; TMaughan; GGriffiths; and SMukherjee;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer [J] . Wu Shi-Xiu, Wang Lv-Hua, Luo Hong-Lei, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：随机化学疗法试验，延长的核心辐照和腹膜细胞癌患者延长的节点辐照和厄洛替尼试验
2. Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials [J] . H M Earl, L Hiller, J A Dunn, British Journal of Cancer . 2012,第8期

机译：早期乳腺癌的佐比表柔比星联合环磷酰胺，甲氨蝶呤和氟尿嘧啶（CMF）与CMF的比较：NEAT | [sol] | BR9601随机III期试验的中位随访时间超过7年
3. Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT|[sol]|BR9601 trials [J] . H M Earl, L Hiller, J A Dunn, British Journal of Cancer . 2012,第8期

机译：早期乳腺癌的佐比表柔比星联合环磷酰胺，甲氨蝶呤和氟尿嘧啶（CMF）与CMF的比较：NEAT | [sol] | BR9601随机III期试验的中位随访时间超过7年
4. Sub-10nm Nanolithography and Direct Pattern Transfer on III-V Compound Semiconductor Using Sol-gel Derived ZrO{sub}2 [C] . Boyang Liu, Seng-Tiong Ho Conference on Lasers and Electro-Optics . 2008

机译：使用溶胶衍生Zro {sub} 2的III-V化合物半导体上的亚10nm纳米光谱和直接图案转移
5. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer [O] . T Crosby, C N Hurt, S Falk, 2017

机译：SCOPE-1的长期结果和复发模式：确定性放化疗+/-西妥昔单抗治疗食管癌的II / III期随机试验
6. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. [O] . Falk, Stephen, Gollins, Simon, Staffurth, John, 2017

机译：SCOPE-1的长期结果和复发模式：确定性放化疗+/-西妥昔单抗治疗食管癌的II / III期随机试验。

Long-term results and recurrence patterns from SCOPE-1: a phase II|[sol]|III randomised trial of definitive chemoradiotherapy |[plus]||[sol]||[minus]| cetuximab in oesophageal cancer

摘要

著录项

相似文献

相关主题

期刊订阅